Cell & Gene Therapies: time for celeb...Six years after the first approved cell and gene therapy, the field is living a renaissance. 5 additional FDA-approved therapies were added in 2022 and could be doubled in 2023, setting a new pace to … more ➔
Cell & Gene Therapies: time for celebr...Six years after the first approved cell and gene therapy, the field is living a renaissance. 5 additional FDA-approved therapies were added in 2022 and could be doubled in 2023, setting a new pace to … more ➔
Sino BiologicalTumor Exosomes: A Messenger for Cancer Pro...Exosomes are extracellular vesicles ranging from 30 to 150 nm in diameter that are released from various types of cells, including tumor cells. They can induce apoptosis, modulate the immune system, … more ➔
AntibodyEvolution of Antibody Humanization and Aff...Antibodies play a vital role in the immune system by providing protection against foreign invaders, such as bacteria and viruses. Produced by B cells, antibodies are protein molecules that can be harnessed … more ➔
Lonza offers PBPK service Physiologically based pharmacokinetic (PBPK) modelling is a tool that can have a huge impact in speeding up drug development. It simulates a range of physiological factors that have an effect on how … more ➔
Membrane ProteinsTransmembrane proteins play a variety of roles in physiological processes such as protein ligation, recognition, transport, anchoring, and transduction. more ➔
Biopharma partnership intensifying purifi...DSP?Tosoh Bioscience recently launched Octave© BIO, the first in a series of MCC instruments targeting all stages of biomolecule manufacturing. Here, Tosoh discusses the potential of MCC to help alleviate … more ➔
Biopharma partnership – intensifying...DSP Tosoh Bioscience recently launched Octave© BIO, the first in a series of MCC instruments targeting all stages of biomolecule manufacturing. Here, Tosoh discusses the potential of MCC to help … more ➔
Inhalation: the potential for faster onset...There is increasing interest in delivering a range of drugs via inhalation because of the benefits it can offer patients. Lonza’s Kim Shepard looks at the advantages of pulmonary delivery, and the prospect … more ➔
Vetter’s Clinical Facility Demonstra...Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development more ➔
